Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, July 2016 / Vol. 65 / No. SS-7

Details

• Alternative Title:
  Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance — the Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries
• Personal Author:
  Kirkcaldy, Robert D. ; Harvey, Alesia ; Papp, John R. ; Del Rio, Carlos ; Soge, Olusegun O. ; Holmes, King K. ; Hook, Edward W. ; Kubin, Grace ; Riedel, Stefan ; Zenilman, Jonathan M. ; Pettus, Kevin ; Sanders, Tremeka ; Sharpe, Samera ; Torrone, Elizabeth
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of STD Prevention
• Description:
  Gonorrhea is the second most commonly reported notifiable disease in the United States; 350,062 gonorrhea cases were reported in 2014. Sexually transmitted infections caused by Neisseria gonorrhoeae are a cause of pelvic inflammatory disease in women, which can lead to serious reproductive Complications including tubal infertility, ectopic pregnancy, and chronic pelvic pain. Prevention of sequelae and of Transmission to sexual partners relies largely on prompt detection and effective antimicrobial treatment. However, treatment has been compromised by the absence of routine antimicrobial susceptibility testing in clinical care and evolution of antimicrobial resistance to the antibiotics used to treat gonorrhea.
  
  The Gonococcal Isolate Surveillance Project (GISP) was established in 1986 as a sentinel Surveillance system to monitor Trends in antimicrobial susceptibilities of N. gonorrhoeae strains in the United States Each month, N. gonorrhoeae isolates are collected from up to the first 25 men with gonococcal urethritis attending each of the participating sexually transmitted disease (STD) clinics at 27 sites. The number of participating sites has varied over time (21–30 per year). Selected demographic and clinical data are abstracted from medical records. Isolates are tested for antimicrobial susceptibility using agar dilution at one of five regional laboratories.
  
  Suggested citation for this article: Kirkcaldy RD, Harvey A, Papp JR, et al. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance — The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014. MMWR Surveill Summ 2016;65(No. SS-7):1–19. DOI: http://dx.doi.org/10.15585/mmwr.ss6507a1.
  
  
• Subjects:
  Drug Resistance, Bacterial Epidemiological Monitoring Gonorrhea / Microbiology Microbial Sensitivity Tests Neisseria Gonorrhoeae / Drug Effects
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Surveillance Summaries, 2016; v. 65, no. 7
• Series:
  Surveillance Summaries: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.ss6507a1
• ISSN:
  1546-0738 (print) ; 1545-8636 (digital)
• Pubmed ID:
  27414503
• Document Type:
  Journal Issue
• Name as Subject:
  Gonococcal Isolate Surveillance Project (U.S.)
• Place as Subject:
  United States
• Pages in Document:
  24 pdf pages
• Volume:
  65
• Issue:
  7
• Collection(s):
  Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:954f6f83c457a8f8698ea51a0a9e6c7923a399552aa3a17f64eb4718bd6746841cdba442f1e4b99e06cd62f78c47e0b057113530f2be9840675bd9b9ec7e4b16
• Download URL:
  https://stacks.cdc.gov/view/cdc/40229/cdc_40229_DS1.pdf
• File Type:
  [PDF - 505.71 KB ]